<DOC>
	<DOCNO>NCT01141049</DOCNO>
	<brief_summary>Primary Hypotheses : 1 . Gabapentin significantly reduce symptom alcohol withdrawal compare placebo . The primary outcome measure alcohol withdrawal Clinical Institute Withdrawal Alcohol ( CIWA-Ar ) ( Sullivan , Sykora , Schneiderman , Naranjo , &amp; Sellers , 1989 ) score . 2 . Gabapentin significantly reduce alcohol consumption promote abstinence compare placebo . The primary outcome measure number heavy drinking day ( defined day number standard drink least 5 men least 4 woman ) per week measure timeline follow-back method . Secondary Hypotheses : 1 . Gabapentin superior placebo reduce alcohol use measure secondary outcome amount drink per day , amount drink per drinking day , percent day abstinent serial measurement gamma-glutamyl transferase ( GGT ) serum level .</brief_summary>
	<brief_title>Gabapentin Abstinence Initiation Alcohol Dependence</brief_title>
	<detailed_description>In 8-week randomized double-blind placebo-controlled outpatient pilot trial efficacy gabapentin treatment alcohol dependence study 60 patient . Participants randomly assign treatment double-blind condition either 1 ) fix dose schedule gabapentin 2 ) placebo . All participant receive weekly supportive behavioral treatment promotes abstinence alcohol substance , encourage mutual-support meeting attendance , facilitate compliance study medication . The primary outcome measure : treatment alcohol withdrawal measure CIWA-Ar reduction heavy drinking day per week measure timeline follow-back method . Participants alcohol-dependent men nonpregnant woman report drink minimum 5 standard drink men 4 standard drink woman least 4 day per week past 28 day . The daily minimum drinking requirement consistent commonly accept definition `` binge drinking . '' A minimum requirement heavy drinking episode 4 day week would select population individual drink excessively day . A minimum threshold weekly alcohol use set prevent `` floor effect '' ( i.e . participant minimal alcohol use baseline would unable demonstrate significant improvement . )</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Between age 1865 . Meets DSMIV criterion current alcohol dependence . Seeking treatment alcohol dependence . Reports drink minimum 5 standard drink men 4 standard drink woman least 4 day per week past 28 day . Able provide inform consent comply study procedure . Lifetime history DSMIV diagnosis schizophrenia , schizoaffective disorder , bipolar disorder . A diagnosis current major depressive disorder current Axis I psychiatric disorder define DSMIVTR , alcohol dependence , investigator 's judgment might require intervention either pharmacological nonpharmacological therapy course study . Patients currently take prescribe psychotropic medication would disrupt study medication effort discontinue alcohol use . Evidence moderatetosevere alcohol withdrawal ( CIWAAr &gt; 13 . History allergic reaction candidate medication ( gabapentin ) . History alcohol withdrawal seizures alcohol withdrawal delirium . Pregnancy , lactation , failure use adequate contraceptive method female patient currently engage sexual activity men . Unstable medical condition , poorly control diabetes hypertension ( &gt; 140/90 mm Hg ) , might make participation hazardous . Subjects current DSMIVTR diagnosis substance dependence , exception nicotine caffeine dependence . A diagnosis substance abuse exclusionary unless significant illicit substance use present . Are legally mandate participate alcohol use disorder treatment program . Who history current assessment represent significant risk suicide . Subjects likely , base history , place danger ( e.g. , drive intoxicated otherwise unwilling follow safety precaution ) . Renal insufficiency abnormal renal function .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Alcohol Withdrawal</keyword>
	<keyword>Reducing Alcohol Consumption</keyword>
	<keyword>Promoting abstinence alcohol-dependent patient</keyword>
	<keyword>Gabapentin</keyword>
</DOC>